SEC Form 4 · accession 0001104659-16-117278
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samir Chandrakant Patel
Officer — President · Director
Period of report
Apr 29, 2016
Accepted (ET)
May 3, 2016 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 29, 2016 | M | 1,413 | $1.652 | A | 231,008 | D | |
| Common Stock | Apr 29, 2016 | M | 1,184 | $13.216 | A | 232,192 | D | |
| Common StockF2 | Apr 29, 2016 | S | 18,435 | $46.71 | D | 213,757 | D | |
| Common StockF3 | Apr 29, 2016 | S | 1,565 | $47.78 | D | 212,192 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F4 | $1.652 | Apr 29, 2016 | M | 1,413 | D | — | Apr 8, 2022 | Common Stock | 1,413 | 0 | D |
| Stock Option (Right To Buy)F5 | $13.216 | Apr 29, 2016 | M | 1,184 | D | — | May 28, 2023 | Common Stock | 1,184 | 15,399 | D |
Explanation of responses
- F1The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2015.
- F2These shares were disposed of in multiple transactions on April 29, 2016 at actual sales prices ranging from $46.16 to $47.15 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3These shares were disposed of in multiple transactions on April 29, 2016 at actual sales prices ranging from $47.24 to $48.05 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4This option was granted on April 9, 2012 and is currently exercisable for all shares underlying the option.
- F5This option was granted on May 29, 2013 and vests over four years, with 2.0833% of the original number of shares underlying the option vesting monthly from the date of grant.